Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials

Name: Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-12-02

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials (English, HTML) HTML
Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials (French, HTML) HTML

Related open data

Health Canada